Pure Global AI
NCT06076967Recruiting

Mindfulness Intervention for College Students With ADHD

University of Alabama, TuscaloosaClinicalTrials.govbehavioral
Verified
Study focus
Disease/Condition
Attention Deficit Hyperactivity Disorder
Drug/Device/Intervention
Mindfulness Awareness Practices for ADHD (adapted)
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
University of Alabama, Tuscaloosa
Location
Tuscaloosa,Spartanburg, United States of America
Timeline & enrollment
Phase
N/A
Start date
Sep 15, 2023
End date
Jul 31, 2026
Enrollment
100 participants
Primary outcome

Conners Adult ADHD Rating Scale,Adult Concentration Inventory,Depression Anxiety Stress Scale-21,Difficulties in Emotion Regulation Scale,Trier Social Stress Test,Mind Excessively Wandering Questionnaire,Five-Facet Mindfulness Questionnaire,Sustained Attention to Response Task,Attention Network Task

Summary

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that
 commonly persists into adulthood and is associated with significant life impairments. The
 current study evaluates the feasibility, acceptability, and preliminary efficacy of a
 group-based mindfulness intervention for first-year college students with ADHD. If found to
 be feasible, acceptable, and efficacious, subsequent research will examine its impact on a
 larger scale to have a broader public health impact for college students with ADHD.

ICD-10 classifications
Neurotic disorder, unspecifiedHyperkinetic disorder, unspecifiedHabit and impulse disorder, unspecifiedMild cognitive disorderDisturbance of activity and attention
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06076967
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06076967 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Alabama, Tuscaloosa and is currently Recruiting. The study focuses on Attention Deficit Hyperactivity Disorder. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.